Literature DB >> 16912010

Primary intraocular lymphoma: A review.

John Y Choi1, Chrysanthi Kafkala, C Stephen Foster.   

Abstract

Primary intraocular lymphoma (PIOL) is a type of primary central nervous system lymphoma (PCNSL). It is the most common neoplastic masquerade syndrome involving the eye. Its protean ocular manifestations, plus in many cases the initial positive response to corticosteroid therapy for presumed uveitis, delay accurate diagnosis. A high index of suspicion is essential, followed by tissue biopsy with cytology and ancillary studies. Current treatment is based on chemotherapy featuring high-dose methotrexate and radiation therapy. Prognosis is poor due to CNS involvement, but newer therapies have had some success in prolonging survival.

Entities:  

Mesh:

Year:  2006        PMID: 16912010     DOI: 10.1080/08820530500350498

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  23 in total

1.  Ocular imaging in primary retinal lymphoma.

Authors:  Chi-Chao Chan; Theodor C Sauer
Journal:  Am J Ophthalmol       Date:  2009-05       Impact factor: 5.258

2.  Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma.

Authors:  Roxana Moslehi; F Bruce Coles; Maria J Schymura
Journal:  Expert Rev Ophthalmol       Date:  2011

3.  Incidence of orbital, conjunctival and lacrimal gland malignant tumors in USA from Surveillance, Epidemiology and End Results, 1973-2009.

Authors:  Waleed M Hassan; Mohamed S Bakry; Housam M Hassan; Ahmad S Alfaar
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

Review 4.  Primary intraocular lymphoma: a review.

Authors:  Gregory S Vosganian; Saskia Boisot; Kathrin I Hartmann; William R Freeman; Robert W Sharpe; Prabhakar Tripuraneni; Alan Saven
Journal:  J Neurooncol       Date:  2011-05-31       Impact factor: 4.130

Review 5.  Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.

Authors:  Gabriella Szatmáry
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

6.  Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma.

Authors:  Noriyasu Hashida; Nobuyuki Ohguro; Kohji Nishida
Journal:  Transl Vis Sci Technol       Date:  2012-10-22       Impact factor: 3.283

7.  Fundus autofluorescence patterns in eyes with primary intraocular lymphoma.

Authors:  Tomoka Ishida; Kyoko Ohno-Matsui; Yuh Kaneko; Hideaki Tobita; Noriaki Shimada; Hiroshi Takase; Manabu Mochizuki
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

8.  Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

Authors:  S A Grimm; C A McCannel; A M P Omuro; A J M Ferreri; J-Y Blay; E A Neuwelt; T Siegal; T Batchelor; K Jahnke; T N Shenkier; A J Hall; F Graus; U Herrlinger; D Schiff; J Raizer; J Rubenstein; N Laperriere; E Thiel; N Doolittle; F M Iwamoto; L E Abrey
Journal:  Neurology       Date:  2008-10-21       Impact factor: 9.910

9.  Cytologic features in vitreous preparations of patients with suspicion of intraocular lymphoma.

Authors:  Erika F Rodriguez; Yasir J Sepah; Hyun Soo Jang; Mohamed Ibrahim; Quan Dong Nguyen; Fausto J Rodriguez
Journal:  Diagn Cytopathol       Date:  2013-10-25       Impact factor: 1.582

10.  Optic Nerve Infiltration in Primary Central Nervous System Lymphoma.

Authors:  Guido Ahle; Valérie Touitou; Nathalie Cassoux; Marie Bouyon; Catherine Humbrecht; Hélène Oesterlé; Alexander Baraniskin; Carole Soussain; Ludovic Nguyen-Them; Claude Gaultier; Khê Hoang-Xuan; Caroline Houillier
Journal:  JAMA Neurol       Date:  2017-11-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.